Peptide Administration Guide: Routes, Techniques & Bioavailability
Complete guide to peptide administration routes — subcutaneous, intramuscular, intranasal, sublingual, and oral — with technique details, bioavailability comparisons, and peptide-specific recommendations.
Different peptide administration routes offer distinct advantages in terms of bioavailability, onset time, convenience, and tissue targeting. This guide covers each route with technique details and peptide-specific considerations.
Route Comparison Overview
| Route | Bioavailability | Onset | Convenience | Best For |
|---|---|---|---|---|
| Intravenous (IV) | 100% (reference) | Immediate | Low (clinical setting) | Emergency, precise dosing |
| Subcutaneous (SC) | 65-95% | 15-30 min | Moderate | Most research peptides |
| Intramuscular (IM) | 75-100% | 10-20 min | Moderate | Local muscle targeting |
| Intranasal (IN) | 10-50% | 5-15 min | High | CNS-targeted peptides |
| Sublingual (SL) | 5-30% | 10-30 min | High | Small peptides |
| Oral (PO) | <1-10% | 30-60 min | Highest | Special formulations only |
| Topical | Variable (local) | Hours | High | Skin peptides |
Subcutaneous Injection
The most common research route for peptides. Delivers the peptide into the fatty tissue layer beneath the skin for gradual systemic absorption.
Technique
- Clean injection site with alcohol swab; allow to dry completely
- Pinch a fold of skin (abdomen, thigh, or upper arm)
- Insert needle at 45-90° angle (depending on subcutaneous fat depth)
- Inject slowly and steadily
- Withdraw needle; apply gentle pressure (do not rub)
- Rotate injection sites to prevent lipodystrophy
Site Selection
| Site | Absorption Rate | Notes |
|---|---|---|
| Abdomen (periumbilical) | Fastest SC absorption | Avoid 2-inch radius around navel |
| Anterior thigh | Moderate absorption | Large surface area for rotation |
| Upper arm (deltoid area) | Moderate absorption | May require assistance |
| Upper buttock | Slowest SC absorption | Less commonly used |
Peptides Commonly Administered SC
Most research peptides: BPC-157, TB-500, GH secretagogues (CJC-1295, Ipamorelin, GHRP-2/6), Epithalon, Thymosin Alpha-1, semaglutide (weekly), and others.
Intramuscular Injection
Delivers peptide directly into muscle tissue. Offers faster absorption than subcutaneous due to greater blood flow in muscle.
Technique
- Clean injection site with alcohol swab
- Spread skin taut (Z-track method preferred)
- Insert needle at 90° angle into muscle belly
- Aspirate briefly to check for blood vessel entry
- Inject slowly
- Withdraw and apply pressure
Common IM Sites
- Deltoid — smaller volume (<2 mL); easy access
- Vastus lateralis (lateral thigh) — larger volume; self-administration friendly
- Ventrogluteal — large volume; low nerve/vessel risk
Peptides Sometimes Administered IM
PEG-MGF (targeting specific muscles), BPC-157 (near injury site), and some GH secretagogue protocols.
Intranasal Administration
Intranasal delivery bypasses the blood-brain barrier via the olfactory and trigeminal nerve pathways, enabling direct CNS access for neuroactive peptides.
Technique
- Clear nasal passages (blow nose gently)
- Tilt head slightly forward
- Insert spray nozzle into nostril, angled slightly outward
- Spray while inhaling gently through the nose
- Alternate nostrils for multi-spray doses
- Avoid blowing nose for 15 minutes after administration
Advantages for Neuroactive Peptides
- Bypasses blood-brain barrier via olfactory nerve transport
- Avoids hepatic first-pass metabolism
- Rapid onset (5-15 minutes for CNS effects)
- Non-invasive; no needles required
Peptides Commonly Administered Intranasally
| Peptide | Intranasal Form | Rationale |
|---|---|---|
| Semax | Nasal drops/spray | Standard Russian administration route; direct CNS access |
| Selank | Nasal drops/spray | Standard Russian administration route; anxiolytic CNS effects |
| N-Acetyl Selank Amidate | Nasal spray | Enhanced stability; CNS targeting |
| Epithalon Nasal | Nasal spray | Pineal gland targeting via CNS access |
| Oxytocin | Nasal spray | Well-established intranasal route for behavioral research |
| DSIP | Nasal spray | Sleep peptide; CNS targeting |
Sublingual Administration
Sublingual delivery places the peptide under the tongue for absorption through the oral mucosa, bypassing GI degradation and first-pass metabolism.
Technique
- Place solution under the tongue
- Hold for 2-5 minutes without swallowing
- Avoid eating or drinking for 15 minutes afterward
- Do not rinse mouth immediately
Limitations
- Absorption is peptide-dependent (molecular size, charge, lipophilicity)
- Larger peptides (>10 amino acids) generally have poor sublingual absorption
- Better suited for small, lipophilic peptides or those with absorption enhancers
Oral Administration
Most peptides are destroyed by gastric acid and proteases, making oral delivery the most challenging route. However, several peptides have achieved oral bioavailability.
Peptides with Demonstrated Oral Activity
| Peptide | Oral Strategy | Notes |
|---|---|---|
| Semaglutide | SNAC absorption enhancer (Rybelsus) | ~1% bioavailability; clinically effective |
| BPC-157 | Gastric-origin stability | Active orally in GI studies; may act locally |
| MK-677 | Non-peptide small molecule | High oral bioavailability (not a true peptide) |
| Orforglipron | Non-peptide small molecule | GLP-1R agonist; high oral bioavailability |
| 5-Amino-1MQ | Small molecule | Oral bioavailability demonstrated |
| Short bioregulators (2-4 aa) | PepT1 transporter absorption | Vilon, Cartalax, Epithalon (limited evidence) |
See Oral Peptides for the complete oral peptide reference.
Topical Administration
Topical application delivers peptides locally to the skin. Most peptides require lipophilic modifications (palmitoylation, acetylation) to penetrate the stratum corneum.
Peptides for Topical Use
- GHK-Cu — cream, serum, or iontophoresis
- Matrixyl — serum formulations
- Argireline — cream/serum
- SNAP-8 — cream/serum
- Decapeptide-12 — brightening formulations
- BPC-157 — wound healing cream (research)
Enhancing Topical Penetration
- Iontophoresis: Electrical current drives charged peptides through skin
- Microneedling: Creates transient channels in stratum corneum
- Liposomal encapsulation: Lipid vesicles fuse with skin lipids
- Chemical enhancers: DMSO, oleic acid, propylene glycol
See Also
Peptide Stacking Guide: Research-Based Combinations
Comprehensive peptide stacking reference — healing, growth hormone, nootropic, longevity, metabolic, and cosmetic stacks with research rationale for each combination.
Peptide Injection Technique: Subcutaneous, Intramuscular, Intranasal & Sublingual
Step-by-step peptide administration techniques for subcutaneous, intramuscular, intranasal, and sublingual routes — with injection sites, angles, safety considerations, and peptide-specific guidance.